Cargando…
Personalized antibiograms for machine learning driven antibiotic selection
BACKGROUND: The Centers for Disease Control and Prevention identify antibiotic prescribing stewardship as the most important action to combat increasing antibiotic resistance. Clinicians balance broad empiric antibiotic coverage vs. precision coverage targeting only the most likely pathogens. We inv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053259/ https://www.ncbi.nlm.nih.gov/pubmed/35603264 http://dx.doi.org/10.1038/s43856-022-00094-8 |
_version_ | 1784696959810928640 |
---|---|
author | Corbin, Conor K. Sung, Lillian Chattopadhyay, Arhana Noshad, Morteza Chang, Amy Deresinksi, Stanley Baiocchi, Michael Chen, Jonathan H. |
author_facet | Corbin, Conor K. Sung, Lillian Chattopadhyay, Arhana Noshad, Morteza Chang, Amy Deresinksi, Stanley Baiocchi, Michael Chen, Jonathan H. |
author_sort | Corbin, Conor K. |
collection | PubMed |
description | BACKGROUND: The Centers for Disease Control and Prevention identify antibiotic prescribing stewardship as the most important action to combat increasing antibiotic resistance. Clinicians balance broad empiric antibiotic coverage vs. precision coverage targeting only the most likely pathogens. We investigate the utility of machine learning-based clinical decision support for antibiotic prescribing stewardship. METHODS: In this retrospective multi-site study, we developed machine learning models that predict antibiotic susceptibility patterns (personalized antibiograms) using electronic health record data of 8342 infections from Stanford emergency departments and 15,806 uncomplicated urinary tract infections from Massachusetts General Hospital and Brigham & Women’s Hospital in Boston. We assessed the trade-off between broad-spectrum and precise antibiotic prescribing using linear programming. RESULTS: We find in Stanford data that personalized antibiograms reallocate clinician antibiotic selections with a coverage rate (fraction of infections covered by treatment) of 85.9%; similar to clinician performance (84.3% p = 0.11). In the Boston dataset, the personalized antibiograms coverage rate is 90.4%; a significant improvement over clinicians (88.1% p < 0.0001). Personalized antibiograms achieve similar coverage to the clinician benchmark with narrower antibiotics. With Stanford data, personalized antibiograms maintain clinician coverage rates while narrowing 69% of empiric vancomycin+piperacillin/tazobactam prescriptions to piperacillin/tazobactam. In the Boston dataset, personalized antibiograms maintain clinician coverage rates while narrowing 48% of ciprofloxacin to trimethoprim/sulfamethoxazole. CONCLUSIONS: Precision empiric antibiotic prescribing with personalized antibiograms could improve patient safety and antibiotic stewardship by reducing unnecessary use of broad-spectrum antibiotics that breed a growing tide of resistant organisms. |
format | Online Article Text |
id | pubmed-9053259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-90532592022-05-20 Personalized antibiograms for machine learning driven antibiotic selection Corbin, Conor K. Sung, Lillian Chattopadhyay, Arhana Noshad, Morteza Chang, Amy Deresinksi, Stanley Baiocchi, Michael Chen, Jonathan H. Commun Med (Lond) Article BACKGROUND: The Centers for Disease Control and Prevention identify antibiotic prescribing stewardship as the most important action to combat increasing antibiotic resistance. Clinicians balance broad empiric antibiotic coverage vs. precision coverage targeting only the most likely pathogens. We investigate the utility of machine learning-based clinical decision support for antibiotic prescribing stewardship. METHODS: In this retrospective multi-site study, we developed machine learning models that predict antibiotic susceptibility patterns (personalized antibiograms) using electronic health record data of 8342 infections from Stanford emergency departments and 15,806 uncomplicated urinary tract infections from Massachusetts General Hospital and Brigham & Women’s Hospital in Boston. We assessed the trade-off between broad-spectrum and precise antibiotic prescribing using linear programming. RESULTS: We find in Stanford data that personalized antibiograms reallocate clinician antibiotic selections with a coverage rate (fraction of infections covered by treatment) of 85.9%; similar to clinician performance (84.3% p = 0.11). In the Boston dataset, the personalized antibiograms coverage rate is 90.4%; a significant improvement over clinicians (88.1% p < 0.0001). Personalized antibiograms achieve similar coverage to the clinician benchmark with narrower antibiotics. With Stanford data, personalized antibiograms maintain clinician coverage rates while narrowing 69% of empiric vancomycin+piperacillin/tazobactam prescriptions to piperacillin/tazobactam. In the Boston dataset, personalized antibiograms maintain clinician coverage rates while narrowing 48% of ciprofloxacin to trimethoprim/sulfamethoxazole. CONCLUSIONS: Precision empiric antibiotic prescribing with personalized antibiograms could improve patient safety and antibiotic stewardship by reducing unnecessary use of broad-spectrum antibiotics that breed a growing tide of resistant organisms. Nature Publishing Group UK 2022-04-08 /pmc/articles/PMC9053259/ /pubmed/35603264 http://dx.doi.org/10.1038/s43856-022-00094-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Corbin, Conor K. Sung, Lillian Chattopadhyay, Arhana Noshad, Morteza Chang, Amy Deresinksi, Stanley Baiocchi, Michael Chen, Jonathan H. Personalized antibiograms for machine learning driven antibiotic selection |
title | Personalized antibiograms for machine learning driven antibiotic selection |
title_full | Personalized antibiograms for machine learning driven antibiotic selection |
title_fullStr | Personalized antibiograms for machine learning driven antibiotic selection |
title_full_unstemmed | Personalized antibiograms for machine learning driven antibiotic selection |
title_short | Personalized antibiograms for machine learning driven antibiotic selection |
title_sort | personalized antibiograms for machine learning driven antibiotic selection |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053259/ https://www.ncbi.nlm.nih.gov/pubmed/35603264 http://dx.doi.org/10.1038/s43856-022-00094-8 |
work_keys_str_mv | AT corbinconork personalizedantibiogramsformachinelearningdrivenantibioticselection AT sunglillian personalizedantibiogramsformachinelearningdrivenantibioticselection AT chattopadhyayarhana personalizedantibiogramsformachinelearningdrivenantibioticselection AT noshadmorteza personalizedantibiogramsformachinelearningdrivenantibioticselection AT changamy personalizedantibiogramsformachinelearningdrivenantibioticselection AT deresinksistanley personalizedantibiogramsformachinelearningdrivenantibioticselection AT baiocchimichael personalizedantibiogramsformachinelearningdrivenantibioticselection AT chenjonathanh personalizedantibiogramsformachinelearningdrivenantibioticselection |